RecruitingAge-related condition
Dominantly Inherited Alzheimer Network (DIAN)
- Sponsor
- Washington University School of Medicine (Academic or other)
- Enrollment
- 700 planned
- Conditions
- Alzheimer's Disease
- Ages
- adults, older adults
- Registry
- NCT00869817
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Primary outcomes
- Positive predictive power of a biomarker or group of biomarkers
- Biomarkers obtained by blood draw, lumbar puncture, MRI, FDG PET, PET amyloid imaging
- Clinical markers also examined from clinical interview and cognitive testing
History
Primary completion expected
Last registry update
Registered
Started
Papers citing this trial
- Clinical and biomarker changes in dominantly inherited Alzheimer's disease
The New England journal of medicine